Phase III trial of zoledronic acid in patients with post-menopausal osteoporosis.
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2013
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Registrational; Therapeutic Use
- Acronyms PMO-HORIZON
- 23 Dec 2010 Preliminary results from a substudy were presented at the 32nd Annual Meeting of the American Society for Bone and Mineral Research.
- 23 Dec 2010 New trial record